Just 1.5% Of Eligible People Have Gotten Updated C-19 Booster Jab

Just 1.5% Of Eligible People Have Gotten Updated COVID Booster Jab

Experts are still gathering real-world data, since the shots were distributed without results from human trials.


Only 1.5% of those eligible to receive the new Covid booster jab – which was tested on just 8 mice, not humans, before the FDA approved it – have taken the updated shot, according to data released Thursday by the Centers for Disease Control and Prevention (CDC).

Approximately 4.4 million people have taken the tweaked booster shot from Pfizer and Moderna after they were rolled out three weeks ago around Labor Day weekend. The bivalent shots were designed to target both the original Covid-19 strain, and the currently circulating Omicron subvariants BA.4 and BA.5, NBC News reports.

I would expect a much higher proportion of Americans to have gotten the booster by this point,” said Yale Medicine infectious diseases specialist, Dr. Scott Robers, who said the relatively low uptake was “demoralizing.”

The fact that this booster came out days before Biden said the pandemic is over is a huge mixed message,” said Roberts, who added that a lack of public awareness surrounding the shots – or the ‘prevailing narrative that the pandemic is ending’ might have hindered the rollout. “Now it’s going to be that much harder to convince those at risk who are on the fence to get a booster.”

As of Tuesday, the US had shipped over 25 million boosters to tens of thousands of sites.

Approximately 80% of the US population has received at least one shot of the primary Covid vaccine, and almost 68% are considered ‘fully vaccinated’ by the CDC – meaning they’ve received two doses of Pfizer or Moderna’s offering, or one dose of Johnson & Johnson’s vaccine.

Experts are still gathering real-world data, since the shots were distributed without results from human trials. Laboratory studies found that the boosters generated strong antibody responses against BA.4 and BA.5, and human trial data showed that a similar vaccine yielded a strong antibody response against the initial omicron strain, BA.1.

Authorization of the bivalent boosters for children ages 5 to 11 may be just weeks away, Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, said at an event this week with the Covid-19 Vaccine Education and Equity Project. -NBC News

Word of the slow uptake comes after Denmark recommended that only those over the age of 50, or who are at risk of developing severe Covid-19, receive the vaccine.


(TLB) published this article from ZeroHedge as written and compiled by Tyler Durden

Header featured image (edited) credit:  Nurse/needle/orginal ZH article

Emphasis added by (TLB) editors



Stay tuned to …


The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.